These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3365915)

  • 1. Clinical pharmacokinetics of imipramine and desipramine in alcoholics and normal volunteers.
    Ciraulo DA; Barnhill JG; Jaffe JH
    Clin Pharmacol Ther; 1988 May; 43(5):509-18. PubMed ID: 3365915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous pharmacokinetics of 2-hydroxyimipramine in alcoholics and normal controls.
    Ciraulo DA; Barnhill JG; Jaffe JH; Ciraulo AM; Tarmey MF
    J Stud Alcohol; 1990 Jul; 51(4):366-72. PubMed ID: 2359311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of imipramine and desipramine.
    Sallee FR; Pollock BG
    Clin Pharmacokinet; 1990 May; 18(5):346-64. PubMed ID: 2185906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic interaction of disulfiram and antidepressants.
    Ciraulo DA; Barnhill J; Boxenbaum H
    Am J Psychiatry; 1985 Nov; 142(11):1373-4. PubMed ID: 4061700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):702-5. PubMed ID: 6726654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine disposition in alcoholics.
    Ciraulo DA; Alderson LM; Chapron DJ; Jaffe JH; Subbarao B; Kramer PA
    J Clin Psychopharmacol; 1982 Feb; 2(1):2-7. PubMed ID: 7068940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Avenoso A; Campo GM; Scordo MG; Caputi AP; Perucca E
    Br J Clin Pharmacol; 1997 Mar; 43(3):315-8. PubMed ID: 9088587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipramine and desipramine disposition in the elderly.
    Abernethy DR; Greenblatt DJ; Shader RI
    J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state kinetics of imipramine in transgenic mice with elevated serum AAG levels.
    Holladay JW; Dewey MJ; Yoo SD
    Pharm Res; 1996 Sep; 13(9):1313-6. PubMed ID: 8893267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
    Bergstrom RF; Peyton AL; Lemberger L
    Clin Pharmacol Ther; 1992 Mar; 51(3):239-48. PubMed ID: 1544284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fluvoxamine on the pharmacokinetics of imipramine and desipramine in healthy subjects.
    Spina E; Pollicino AM; Avenoso A; Campo GM; Perucca E; Caputi AP
    Ther Drug Monit; 1993 Jun; 15(3):243-6. PubMed ID: 8333005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the route of administration of imipramine on imipramine and desipramine blood levels.
    Rigal J; Albin H; Fança X; Demotes-Mainard F; Vinçon G
    J Clin Psychopharmacol; 1989 Oct; 9(5):364-7. PubMed ID: 2677063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramine.
    Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1989; 37(2):155-60. PubMed ID: 2792169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sertraline on the pharmacokinetics of desipramine and imipramine.
    Kurtz DL; Bergstrom RF; Goldberg MJ; Cerimele BJ
    Clin Pharmacol Ther; 1997 Aug; 62(2):145-56. PubMed ID: 9284850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study on desipramine pharmacokinetics in the rat brain after administration of desipramine or imipramine.
    Daniel W; Melzacka M
    J Pharm Pharmacol; 1992 May; 44(5):429-32. PubMed ID: 1359059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of depression to very high plasma levels of imipramine plus desipramine.
    Garvey M; DeRubeis RJ; Hollon SD; Evans MD; Tuason VB
    Biol Psychiatry; 1991 Jul; 30(1):57-62. PubMed ID: 1892963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic correlation between in vitro hepatic microsomal enzyme kinetics and in vivo metabolism of imipramine and desipramine in rats.
    Chiba M; Fujita S; Suzuki T
    J Pharm Sci; 1990 Apr; 79(4):281-7. PubMed ID: 2352136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of In Vitro Data and Physiologically-Based Pharmacokinetic Modeling to Predict Drug Metabolite Exposure: Desipramine Exposure in Cytochrome P4502D6 Extensive and Poor Metabolizers Following Administration of Imipramine.
    Nguyen HQ; Callegari E; Obach RS
    Drug Metab Dispos; 2016 Oct; 44(10):1569-78. PubMed ID: 27440861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.